M&A Deal Summary

Cynapsus Therapeutics Acquires Adagio Pharmaceuticals

On April 17, 2011, Cynapsus Therapeutics acquired life science company Adagio Pharmaceuticals

Acquisition Highlights
  • This is Cynapsus Therapeutics’ 1st transaction in the Life Science sector.
  • This is Cynapsus Therapeutics’ 1st transaction in Canada.
  • This is Cynapsus Therapeutics’ 1st transaction in Ontario.

M&A Deal Summary
Date 2011-04-17
Target Adagio Pharmaceuticals
Sector Life Science
Buyer(s) Cynapsus Therapeutics
Deal Type Add-on Acquisition

Target

Adagio Pharmaceuticals

Oakville, Ontario, Canada
Adagio Pharmaceuticals Ltd. is a specialty pharmaceutical company.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Cynapsus Therapeutics

Toronto, Ontario, Canada
Category Company
Sector Life Science
DESCRIPTION

Cynapsus Therapeutics, Inc. is a specialty central nervous system pharmaceutical company that has been developing a fast-acting, easy-to-use, sublingual thin film for the on-demand management of debilitating OFF episodes associated with PD.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Ontario) 1 of 1
Country (Canada) 1 of 1
Year (2011) 1 of 1
Mergr

Product

Company

Legal